Valuation: Supergenics

Market Cap 29.11M 7.13M 6.22M 5.87M 5.33M 9.99M 684M 10.03M 70.35M 27.15M 348M 26.8M 26.2M 1.12B P/E 2024
-9.45x
P/E 2025 -8.61x
Enterprise Value 32.5M 7.97M 6.95M 6.56M 5.96M 11.16M 764M 11.2M 78.56M 30.32M 389M 29.92M 29.26M 1.25B EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 year 0.2
Extreme 0.205
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 24/04/2019
Corporate Secretary - 02/06/2022
Director TitleAgeSince
Director/Board Member 48 24/04/2019
Director/Board Member 60 24/04/2019
Director/Board Member 46 28/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%-16.67%+8.70% 7.13M
+0.11%+2.71%+0.44%+26.85% 46.28B
-1.12%+1.78%+42.30%+27.55% 43.85B
-3.04%-6.29%+338.56%+515.97% 40.93B
-0.74%+1.25%+4.92%+67.98% 39.89B
-0.50%+0.67%+10.29%+41.28% 29.5B
-0.46%+4.22%+22.81%+139.44% 17.09B
-0.97%-10.17% - - 15.55B
-0.57%+8.12%+22.19%+38.68% 15.22B
-3.14%+31.91%-11.79% - 14.05B
Average +1.15%+3.39%+45.89%+108.31% 26.24B
Weighted average by Cap. -1.10%+1.87%+68.04%+130.90%

Financials

2024 2025
Net sales 5.32M 1.3M 1.14M 1.07M 975K 1.83M 125M 1.83M 12.86M 4.96M 63.62M 4.9M 4.79M 205M 5.63M 1.38M 1.2M 1.14M 1.03M 1.93M 132M 1.94M 13.6M 5.25M 67.25M 5.18M 5.06M 216M
Net income -7.28M -1.78M -1.56M -1.47M -1.33M -2.5M -171M -2.51M -17.6M -6.79M -87.05M -6.7M -6.55M -280M -3.37M -825K -719K -679K -617K -1.16M -79.14M -1.16M -8.13M -3.14M -40.24M -3.1M -3.03M -129M
Net Debt 4.48M 1.1M 957K 903K 820K 1.54M 105M 1.54M 10.82M 4.18M 53.52M 4.12M 4.03M 172M 3.39M 832K 725K 685K 622K 1.17M 79.81M 1.17M 8.2M 3.17M 40.58M 3.12M 3.06M 131M
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!